Takahashi S, Sagawa M, Sato M, Usuda K, Sugama K, Nagamoto N, Saito Y, Nakada T, Fujimura S
Department of Surgery, Research Institute for Chest Disease and Cancer, Tohoku University.
Kyobu Geka. 1991 Mar;44(3):215-8.
We analyzed stage III and IV lung cancer with tumor size smaller than 3.0 cm. The percentage of adenocarcinoma among the patients with stage III A lung cancer was high. In survival rate, there was no observable difference between the patients with tumor size smaller than 3.0 cm and the patients with tumor size larger than 3.1 cm. But the ratio of the people who had a long survival was high in the latter group. Among the stage IV patients, the pm 1 group with N0 or N1 had a good prognosis (52%, 50% at 5 years).
我们分析了肿瘤大小小于3.0厘米的Ⅲ期和Ⅳ期肺癌。ⅢA期肺癌患者中腺癌的比例较高。在生存率方面，肿瘤大小小于3.0厘米的患者与肿瘤大小大于3.1厘米的患者之间没有明显差异。但后一组中生存期长的患者比例较高。在Ⅳ期患者中，N0或N1的pm 1组预后良好（5年生存率分别为52%、50%）。
